Davies R A, Patt N L, Sole M J
Can Med Assoc J. 1979 Mar 3;120(5):539-42.
The diagnosis of pheochromocytoma rests primarily on determination of the 24-hour urinary excretion of catecholamines and their metabolites. In most cases nephrotomography and selective arteriography or venography, or both, are sufficient to localize the tumour. Selective venous catheterization and the assay of plasma catecholamines should be considered for pheochromocytoma localization in: (a) patients in whom standard techniques fail to localize the tumour; (b) patients who exhibit idiosyncratic reactions to the angiographic contrast materials; (c) young patients or patients with familial pheochromocytoma, including those with multiple neurofibromatosis or multiple endocrine adenomatosis, type 2; (d) patients with recurrent, malignant, or suspected multicentric or extra-adrenal tumours; and (e) patients excreting only norepinephrine in the urine. The validity of the results is particularly dependent on the skill with which venous catheterization is carried out.
嗜铬细胞瘤的诊断主要基于24小时尿儿茶酚胺及其代谢产物排泄量的测定。在大多数情况下,肾断层摄影术和选择性动脉造影或静脉造影,或两者兼用,足以确定肿瘤的位置。对于以下情况的嗜铬细胞瘤定位,应考虑选择性静脉插管和血浆儿茶酚胺测定:(a) 标准技术未能确定肿瘤位置的患者;(b) 对血管造影造影剂表现出特异反应的患者;(c) 年轻患者或患有家族性嗜铬细胞瘤的患者,包括患有多发性神经纤维瘤病或2型多发性内分泌腺瘤病的患者;(d) 患有复发性、恶性或疑似多中心或肾上腺外肿瘤的患者;以及(e) 尿中仅排泄去甲肾上腺素的患者。结果的有效性尤其取决于静脉插管操作的熟练程度。